Rawan H Al-Kady

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Parkinson Disease

Top Venues

ACS chemical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Tarek Mohamed Kamal Motawi, Rawan H Al-Kady, Mahmoud A Senousy, Sahar M Abdelraouf
Repaglinide Elicits a Neuroprotective Effect in Rotenone-Induced Parkinson's Disease in Rats: Emphasis on Targeting the DREAM-ER Stress BiP/ATF6/CHOP Trajectory and Activation of Mitophagy. ACS chemical neuroscience 14 (1) (2022)
Tarek Mohamed Kamal Motawi, Rawan H Al-Kady, Mahmoud A Senousy, Sahar M Abdelraouf
Repaglinide Elicits a Neuroprotective Effect in Rotenone-Induced Parkinson's Disease in Rats: Emphasis on Targeting the DREAM-ER Stress BiP/ATF6/CHOP Trajectory and Activation of Mitophagy. ACS chemical neuroscience 14 (1) (2022)
Tarek Mohamed Kamal Motawi, Rawan H Al-Kady, Mahmoud A Senousy, Sahar M Abdelraouf
Repaglinide Elicits a Neuroprotective Effect in Rotenone-Induced Parkinson's Disease in Rats: Emphasis on Targeting the DREAM-ER Stress BiP/ATF6/CHOP Trajectory and Activation of Mitophagy. ACS chemical neuroscience (2022)
Tarek Mohamed Kamal Motawi, Rawan H Al-Kady, Mahmoud A Senousy, Sahar M Abdelraouf
Repaglinide Elicits a Neuroprotective Effect in Rotenone-Induced Parkinson's Disease in Rats: Emphasis on Targeting the DREAM-ER Stress BiP/ATF6/CHOP Trajectory and Activation of Mitophagy. ACS chemical neuroscience 14 (1) (2022)
Tarek Mohamed Kamal Motawi, Rawan H Al-Kady, Mahmoud A Senousy, Sahar M Abdelraouf
Repaglinide Elicits a Neuroprotective Effect in Rotenone-Induced Parkinson's Disease in Rats: Emphasis on Targeting the DREAM-ER Stress BiP/ATF6/CHOP Trajectory and Activation of Mitophagy. ACS chemical neuroscience 14 (1) (2022)